نحوه مصرف
توصیه های دارویی کندر
منابع
1-Krohn K, Rao MS, Raman NV and Khalilullah M. HPTLC analysis of anti-inflammatory triterpenoids from Boswellia serrata Roxb. Phytochemical Analysis 2001; 12: 374 - 6.
2-Shailesh AS, Ishwarsinh SR, Bhanubhai NS,Dharmesh AP, Vijay KP, Bharat KS and Vikas MV. Estimation of boswellic acids from market formulations of Boswellia serrata extract and 11- keto -boswellic acid in human plasma by highperformance thin-layer chromatography. J. of Chromatography B, 2007; 848: 232 - 8.
3-Poeckel D and Werz O. Boswellic acids:biological actions and molecular targets. Curr Med. Chem, 2006; 13: 3359 -69.
4-Safayhi H, Mack T, Sabieraj J, Anazodo M,Subramanian LR, and Ammon HPT. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 1992; 261:1143 -6.
5-Singh GB and Atal CK. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new nonsteroidal anti-inflammatory agent. Agents Actions 1986; 18: 407 - 12.
6-Borrelli F, Capasso F, Capasso R, Ascione V,Aviello G, Longo R and Izzo AA. Effect of Boswellia serrata on intestinal motility in rodents:inhibition of diarrhea without constipation. Br. J. Pharmacol. 2006; 148: 553 - 60.
7-Shao Y, Ho CT and Chin CK. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture.Planta Med. 1998; 64: 328 - 31.
8-Kavitha JV, Rosario JF, Chandran J, Anbu P and Bakkiyanathan. Hypoglycemic and other related effects of Boswellia glabra in alloxaninduced diabetic rats. Indian J. Physiol. Pharmacol. 2007; 51: 29 - 39.
9-Camarda L, Dayton T, Di Stefano V, Pitonzo R and Schillaci D. Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia spp. (Burseraceae).Ann Chim. 2007; 97: 837 - 44.